Tags: myelofibrosisinpatient to outpatient transitionsmedication reconciliationplateletsplatelet
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 2 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | Arcellx to present positive data on multiple myeloma treatments - about 2 months ago Scotland first in UK to approve new myeloma treatment - 4 months ago | |
| 3 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California | ||
| 4 | Emily Cooke Live Science Health reporter. London, United Kingdom | ||
| 5 | Judy George MedPage Today Medical reporter, writer. | ||
| 6 | Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA | Final Thoughts - about 1 month ago | |
| 7 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
| 8 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | FDA Extends Approval of Fibryga to Include Bleeding Patients With Acquired Fibrinogen Deficiency - 5 months ago FDA Approves Idecabtagene Vicleucel for Multiple Myeloma After 2 or More Lines of Therapy - 9 months ago | |
| 9 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 6 months ago Why Some Myeloma Patients Refuse Stem Cell Transplant - about 1 year ago High NfL Levels Predict Greater MS Disability Within 2 Years - about 1 year ago | |
| 10 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | FDA Panel Endorses Imetelstat for MDS-Related Anemia - 10 months ago FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia - 10 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 11 months ago Ruxolitinib Combinations Reduce Spleen Volume in Myelofibrosis - about 1 year ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - about 1 year ago |